New medical breakthroughs

•Download as PPTX, PDF•

2 likes•481 views

Scientists have made new medical discoveries in neuroscience and stem cell research. Stem cells are described as the keystone of life, holding great potential for new medical treatments and breakthroughs. Further research is being conducted to advance understanding and applications of stem cells and neuroscience.

Health & Medicine

NEUROSCIENCE STEM CELLS, The Keystone of life

Recently uploaded

Colonic and anorectal physiology with surgical implications

Dr Maria Tamanna

Top 10 Best Ayurvedic Kidney Stone Syrups in India

SwastikAyurveda

Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS

AkankshaAshtankar

Pictures of Superficial & Deep Fascia.ppt.pdf

Dr. Rabia Inam Gandapore

Sex determination from mandible pelvis and skull

ShashankRoodkee

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...

kevinkariuki227

Knee anatomy and clinical tests 2024.pdf

vimalpl1234

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

Oleg Kshivets

RESULTS: Overall life span (LS) was 2252.1±1742.5 days and cumulative 5-year survival (5YS) reached 73.2%, 10 years – 64.8%, 20 years – 42.5%. 513 LCP lived more than 5 years (LS=3124.6±1525.6 days), 148 LCP – more than 10 years (LS=5054.4±1504.1 days).199 LCP died because of LC (LS=562.7±374.5 days). 5YS of LCP after bi/lobectomies was significantly superior in comparison with LCP after pneumonectomies (78.1% vs.63.7%, P=0.00001 by log-rank test). AT significantly improved 5YS (66.3% vs. 34.8%) (P=0.00000 by log-rank test) only for LCP with N1-2. Cox modeling displayed that 5YS of LCP significantly depended on: phase transition (PT) early-invasive LC in terms of synergetics, PT N0—N12, cell ratio factors (ratio between cancer cells- CC and blood cells subpopulations), G1-3, histology, glucose, AT, blood cell circuit, prothrombin index, heparin tolerance, recalcification time (P=0.000-0.038). Neural networks, genetic algorithm selection and bootstrap simulation revealed relationships between 5YS and PT early-invasive LC (rank=1), PT N0—N12 (rank=2), thrombocytes/CC (3), erythrocytes/CC (4), eosinophils/CC (5), healthy cells/CC (6), lymphocytes/CC (7), segmented neutrophils/CC (8), stick neutrophils/CC (9), monocytes/CC (10); leucocytes/CC (11). Correct prediction of 5YS was 100% by neural networks computing (area under ROC curve=1.0; error=0.0). CONCLUSIONS: 5YS of LCP after radical procedures significantly depended on: 1) PT early-invasive cancer; 2) PT N0--N12; 3) cell ratio factors; 4) blood cell circuit; 5) biochemical factors; 6) hemostasis system; 7) AT; 8) LC characteristics; 9) LC cell dynamics; 10) surgery type: lobectomy/pneumonectomy; 11) anthropometric data. Optimal diagnosis and treatment strategies for LC are: 1) screening and early detection of LC; 2) availability of experienced thoracic surgeons because of complexity of radical procedures; 3) aggressive en block surgery and adequate lymph node dissection for completeness; 4) precise prediction; 5) adjuvant chemoimmunoradiotherapy for LCP with unfavorable prognosis.

NVBDCP.pptx Nation vector borne disease control program

Sapna Thakur

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx

Swetaba Besh

Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences

Yodley Lifesciences

planning for change nursing Management ppt

Thangamjayarani

basicmodesofventilation2022-220313203758.pdf

aljamhori teaching hospital

Cervical & Brachial Plexus By Dr. RIG.pptx

Dr. Rabia Inam Gandapore

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade

Prof. Marcus Renato de Carvalho

Recomendações da OMS sobre cuidados maternos e neonatais para uma experiência pós-natal positiva. Em consonância com os ODS – Objetivos do Desenvolvimento Sustentável e a Estratégia Global para a Saúde das Mulheres, Crianças e Adolescentes, e aplicando uma abordagem baseada nos direitos humanos, os esforços de cuidados pós-natais devem expandir-se para além da cobertura e da simples sobrevivência, de modo a incluir cuidados de qualidade. Estas diretrizes visam melhorar a qualidade dos cuidados pós-natais essenciais e de rotina prestados às mulheres e aos recém-nascidos, com o objetivo final de melhorar a saúde e o bem-estar materno e neonatal. Uma “experiência pós-natal positiva” é um resultado importante para todas as mulheres que dão à luz e para os seus recém-nascidos, estabelecendo as bases para a melhoria da saúde e do bem-estar a curto e longo prazo. Uma experiência pós-natal positiva é definida como aquela em que as mulheres, pessoas que gestam, os recém-nascidos, os casais, os pais, os cuidadores e as famílias recebem informação consistente, garantia e apoio de profissionais de saúde motivados; e onde um sistema de saúde flexível e com recursos reconheça as necessidades das mulheres e dos bebês e respeite o seu contexto cultural. Estas diretrizes consolidadas apresentam algumas recomendações novas e já bem fundamentadas sobre cuidados pós-natais de rotina para mulheres e neonatos que recebem cuidados no pós-parto em unidades de saúde ou na comunidade, independentemente dos recursos disponíveis. É fornecido um conjunto abrangente de recomendações para cuidados durante o período puerperal, com ênfase nos cuidados essenciais que todas as mulheres e recém-nascidos devem receber, e com a devida atenção à qualidade dos cuidados; isto é, a entrega e a experiência do cuidado recebido. Estas diretrizes atualizam e ampliam as recomendações da OMS de 2014 sobre cuidados pós-natais da mãe e do recém-nascido e complementam as atuais diretrizes da OMS sobre a gestão de complicações pós-natais. O estabelecimento da amamentação e o manejo das principais intercorrências é contemplada. Recomendamos muito. Vamos discutir essas recomendações no nosso curso de pós-graduação em Aleitamento no Instituto Ciclos. Esta publicação só está disponível em inglês até o momento. Prof. Marcus Renato de Carvalho www.agostodourado.com

CDSCO and Phamacovigilance {Regulatory body in India}

NEHA GUPTA

The Central Drugs Standard Control Organization (CDSCO) is India's national regulatory body for pharmaceuticals and medical devices. Operating under the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India, the CDSCO is responsible for approving new drugs, conducting clinical trials, setting standards for drugs, controlling the quality of imported drugs, and coordinating the activities of State Drug Control Organizations by providing expert advice. Pharmacovigilance, on the other hand, is the science and activities related to the detection, assessment, understanding, and prevention of adverse effects or any other drug-related problems. The primary aim of pharmacovigilance is to ensure the safety and efficacy of medicines, thereby protecting public health. In India, pharmacovigilance activities are monitored by the Pharmacovigilance Programme of India (PvPI), which works closely with CDSCO to collect, analyze, and act upon data regarding adverse drug reactions (ADRs). Together, they play a critical role in ensuring that the benefits of drugs outweigh their risks, maintaining high standards of patient safety, and promoting the rational use of medicines.

Ophthalmology Clinical Tests for OSCE exam

KafrELShiekh University

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx

Dr. Rabia Inam Gandapore

Light House Retreats: Plant Medicine Retreat Europe

Lighthouse Retreat

Recently uploaded (20)

Colonic and anorectal physiology with surgical implications

Top 10 Best Ayurvedic Kidney Stone Syrups in India

Adv. biopharm. APPLICATION OF PHARMACOKINETICS : TARGETED DRUG DELIVERY SYSTEMS

Pictures of Superficial & Deep Fascia.ppt.pdf

Sex determination from mandible pelvis and skull

TEST BANK for Operations Management, 14th Edition by William J. Stevenson, Ve...

Knee anatomy and clinical tests 2024.pdf

Pharynx and Clinical Correlations BY Dr.Rabia Inam Gandapore.pptx

Lung Cancer: Artificial Intelligence, Synergetics, Complex System Analysis, S...

NVBDCP.pptx Nation vector borne disease control program

ANATOMY AND PHYSIOLOGY OF URINARY SYSTEM.pptx

Pharma Pcd Franchise in Jharkhand - Yodley Lifesciences

planning for change nursing Management ppt

basicmodesofventilation2022-220313203758.pdf

Cervical & Brachial Plexus By Dr. RIG.pptx

Novas diretrizes da OMS para os cuidados perinatais de mais qualidade

CDSCO and Phamacovigilance {Regulatory body in India}

Ophthalmology Clinical Tests for OSCE exam

Thyroid Gland- Gross Anatomy by Dr. Rabia Inam Gandapore.pptx

Light House Retreats: Plant Medicine Retreat Europe